US EditionOtsuka Pharmaceutical Competes with Vera Therapeutics in Kidney Disease Treatments Amid GLP-1 Drug Eye Risk Concerns
Summary by GeneOnline News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Otsuka Pharmaceutical Competes with Vera Therapeutics in Kidney Disease Treatments Amid GLP-1 Drug Eye Risk Concerns
A recent update in the biotech sector highlights develo […] The post Otsuka Pharmaceutical Competes with Vera Therapeutics in Kidney Disease Treatments Amid GLP-1 Drug Eye Risk Concerns first appeared on GeneOnline News. The post Otsuka Pharmaceutical Competes with Vera Therapeutics in Kidney Disease Treatments Amid GLP-1 Drug Eye Risk Concerns appeared first on GeneOnline News.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
